Xenis Medical earned the FDA’s 510(k) clearance for the Riva posterior fixation system and launched the device, according to a June 2 news release.
The system has a modular design and tulip head and screw shank options to address complex spinal anatomy and construct challenges. It features a single-step head attachment and removal mechanism, allowing surgeons to attach and detach the tulip head with straightforward instrumentation.
Xenix Medical is working to integrate its proprietary NanoACTIV surface technology in to the Riva system.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
